Development and Testing of the Quality of Life in Children with Vernal Keratoconjunctivitis Questionnaire

Sacchetti, Marta; Baiardini, Ilaria; Lambìase, Alessandro; Aronni, Silvia; Fassio, Omar; Gramiccioni, Claudia; Bonini, Sergio; Bombardieri, Stefano

doi:10.1016/j.ajo.2007.06.028

Cited by 93 publications

(96 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Of 17 identified instruments, all but one43 were developed and validated using the English language (although in different versions). Six are intended for the broader population of children and young people with VI, irrespective of the eye condition (referred to as ‘all-cause generic VI instruments’) (table 2) and 11 for children with specific ophthalmic conditions (referred to as ‘eye disorder-specific instruments’) (table 3).…”

Section: Resultsmentioning

confidence: 99%

Patient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic review

et al. 2013

View full text Add to dashboard Cite

198/200; Main text 4099/4000. Refs 85; Tables 1; Figures 1; Appendices 7. 2 CHESS PROMs review Cephalgia FTC:110117 Re-submit 240517 Tables edited 270717 Structured Abstract: (198/200) Aims To critically appraise, compare and synthesise the quality and acceptability of multi-item PROMs for adults with chronic or episodic headache. Methods Systematic literature searches of major databases (1980-2016) to identify published evidence of PROM measurement and practical properties. Data on study quality (COSMIN), measurement and practical properties per measure was extracted and assessed against accepted standards to inform an evidence synthesis. Results From 10,903 reviewed abstracts, 103 articles were assessed in full; 46 provided evidence for 23 PROMs: eleven specific to the health-related impact of migraine (n=5) or headache (n=6); six assessed migraine-specific treatment response/satisfaction; six were generic measures. Evidence for measurement validity and score interpretation was strongest for two measures of impact-Migraine-Specific Quality of Life Questionnaire (MSQ v2.1) and Headache Impact Test 6-item (HIT-6), and one of treatment response-the Patient Perception of Migraine Questionnaire (PPMQ-R). Evidence of reliability was limited, but acceptable for the HIT-6. Responsiveness was rarely evaluated. Evidence for the remaining measures was limited. Patient involvement was limited and poorly reported. Conclusion Whilst evidence is limited, three measures have acceptable evidence of reliability and validity-HIT-6, MSQ v2.1 and PPMQ-R. Only the HIT-6 has acceptable evidence supporting its completion by all 'headache' populations.

show abstract

Section: Resultsmentioning

confidence: 99%

Patient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic review

et al. 2013

View full text Add to dashboard Cite

show abstract

“…In addition to their intense ocular discomfort, children with CAC often experience negative consequences because of the limitation of many of their preferred activities and social interactions [14]. These patients may also develop disease-related and/or iatrogenic complications with ocular morbidity and even blindness.…”

Section: Discussionmentioning

confidence: 99%

Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis

et al. 2012

View full text Add to dashboard Cite

To evaluate the efficacy and safety of supratarsal injection of triamcinolone acetonide in the treatment of refractory allergic keratoconjunctivitis in childhood. Thirty-five patients (70 eyes) with severe allergic keratoconjunctivitis were included in this study. Fifteen patients (42.8%) had atopic keratoconjunctivitis (AKC) and 20 (57.2%) had vernal keratoconjuncivitis (VKC). All patients underwent a bilateral supratarsal injection of 20 mg triamcinolone acetonide. Mean follow-up was 28 months (range 14-38). All patients showed a significant symptomatic improvement and partial resolution of clinical features of keratoconjunctivitis within the first 2 weeks. Corneal complications related to keratoconjunctivitis disappeared in all patients. One patient with VKC experienced ocular hypertension. No patient with AKC showed side-effects. Severe relapse of the disease was noted in 10% of eyes with VKC and in 6.7% of eyes with AKC after a mean follow-up of 9 and 11 months, respectively. Supratarsal injection of triamcinolone acetonide is effective and safe in patients with severe chronic allergic keratoconjunctivits to relieve severe inflammation associated with this disease.

show abstract

“…[44][45][46] The quality of life is reported to get worse if eye symptoms are added to the clinical picture in allergic rhinoconjunctivitis, which supports the importance of eye involvement in allergic diseases. 34,47 As well as physical symptoms, psychiatric disorders, such as depression, is also reported to have negative effect on quality of life.…”

Section: Discussionmentioning

confidence: 91%

Psychiatric Evaluation of Children with Vernal Keratoconjunctivitis

Palamar¹,

Özbaran²,

Erermiş³

et al. 2013

Turkiye Klinikleri J Med Sci

View full text Add to dashboard Cite

A AB BS S T TR RA AC CT T O Ob b j je ec c t ti i v ve e: : To eva lu a te the psychi at ric ef fects of ver nal ke ra to con junc ti vi tis (VKC) in chil dren. M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : Psychi at ric eva lu a ti on forms we re fil led out thro ugh an in ter view with 25 chil dren with ver nal ke ra to con junc ti vi tis (VKC, study gro up) and 36 myo pic (-0.50 and -1.50 D) and ot her wi se he althy chil dren (con trol gro up). Both gro ups' mot hers fil led the Child Beha vi or Check List (CBCL). All chil dren fil led the Chil dren Dep res si on In ven tory (CDI), the Sta teTra it An xi ety In ven tory (STA I), and we re in ter vi e wed using Kid di e Sche du le for Af fec ti ve Di sor ders and Schi zop hre ni a. The Di ag nos tic and Sta tis ti cal Ma nu al for Psychi at ric Di sor ders, 4th edi ti on was used for psychi at ric di ag no sis. R Re e s su ul lt ts s: : The CBCL sco res of ac ti vi ti es (p<0.0001), and soci a bi lity (p=0.003) we re sig ni fi cantly lo wer, and the sco res of with drawn (p=0.48), so ma ti za ti on (p<0.0001), an xi ety dep res si on (p=0.045), at ten ti on prob lems (p=0.001), to tal prob lems (p=0.020), inter na li zing (p=0.001) we re sig ni fi cantly hig her in the study gro up. The sco res of STA -I I (p<0.0001) and STA I II (p<0.0001) we re sig ni fi cantly hig her in the study gro up. The CDI sco res of the study gro up we re sig ni fi cantly hig her (p<0.0001). A psychi at ric di ag no sis was ma de in 64.00% of the study gro up, and in 2.77% of the con trol gro up pa ti ents (p< 0.0001). C Co on nc c l lu u s si i o on n: : VKC is a chro nic di sor der which af fects the ac ti vity and so ci a bi lity of chil dren, and tends to ca u se dep res sion and an xi ety di sor ders. Oph thal mo lo gists sho uld be awa re of the pos sib le psychi at ric ef fects of VKC in pe di at ric po pu la ti on, and sho uld re mem ber to con sult the se chil dren to child psychi atrists.K Ke ey y W Wo or rd ds s: : An xi ety; child; dep res si on; myo pi a; psychi at ric sta tus ra ting sca les; con junc ti vi tis, al ler gic Ö ÖZ ZE ET T A Am ma aç ç: : Ver nal ke ra to kon jonk ti vi tin ço cuk lar da ki psi ki at rik et ki le ri nin de ğer len di ril me si. G Ge e r re eç ç v ve e Y Yö ön n t te em m l le er r: : Yir mi beş ver nak ke ra to kon juk ti vit li (VKK, ça lış ma gru bu) ve 36 mi yo pik olup di ğer yön ler den sağ lık lı (kon trol grup) ço cuk lar la gö rüş me son ra sı psi ki yat rik de ğer len dir me form la rı dol du rul muş tur. Her iki grup ço cuk la rın an ne le ri, ço cuk la rı için dav ra nış de ğer len dir me öl çe ği ni (ÇDDÖ) dol dur muş lar dır. Tüm ço cuk lar için dep res yon en van te ri ni (ÇDE), du rum lu luksü rek li lik ank si ye te en van te ri ni (DSKE) dol dur muş lar ve gö rüş me le ri ço cuk lar için af fek tif bo zukluk lar ve şizof re ni gö rüş me çi zel ge si kul la nı la rak ya pıl mış tır. B Bu ul l g gu u l la ar r: : CDDÖ alt öl çek le rin den ak ti vi te (p<,.0001) ve sos yal lik (p=0,003) an lam lı ola rak d...

show abstract

Development and Testing of the Quality of Life in Children with Vernal Keratoconjunctivitis Questionnaire

Cited by 93 publications

References 20 publications

Patient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic review

Patient-reported outcome measures (PROMs) in paediatric ophthalmology: a systematic review

Supratarsal injection of triamcinolone acetonide and childhood allergic keratoconjunctivitis

Psychiatric Evaluation of Children with Vernal Keratoconjunctivitis

Contact Info

Product

Resources

About